Northeast Financial Consultants’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,000
| Closed | -$9.6K | – | 298 |
|
|
2023
Q2 | $9.6K | Hold |
10,000
| – | – | ﹤0.01% | 288 |
|
|
2023
Q1 | $7.5K | Hold |
10,000
| – | – | ﹤0.01% | 317 |
|
|
2022
Q4 | $3.69K | Hold |
10,000
| – | – | ﹤0.01% | 320 |
|
|
2022
Q3 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 335 |
|
|
2022
Q2 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 331 |
|
|
2022
Q1 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 387 |
|
|
2021
Q4 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 356 |
|
|
2021
Q3 | $22K | Hold |
10,000
| – | – | ﹤0.01% | 352 |
|
|
2021
Q2 | $38K | Hold |
10,000
| – | – | ﹤0.01% | 347 |
|
|
2021
Q1 | $33K | Hold |
10,000
| – | – | ﹤0.01% | 328 |
|
|
2020
Q4 | $34K | Hold |
10,000
| – | – | ﹤0.01% | 318 |
|
|
2020
Q3 | $41K | Hold |
10,000
| – | – | ﹤0.01% | 299 |
|
|
2020
Q2 | $34K | Hold |
10,000
| – | – | ﹤0.01% | 290 |
|
|
2020
Q1 | $23K | Hold |
10,000
| – | – | ﹤0.01% | 269 |
|
|
2019
Q4 | $36K | Hold |
10,000
| – | – | ﹤0.01% | 303 |
|
|
2019
Q3 | $83K | Hold |
10,000
| – | – | 0.01% | 317 |
|
|
2019
Q2 | $86K | Hold |
10,000
| – | – | 0.01% | 321 |
|
|
2019
Q1 | $107K | Hold |
10,000
| – | – | 0.01% | 311 |
|
|
2018
Q4 | $88K | Hold |
10,000
| – | – | 0.01% | 154 |
|
|
2018
Q3 | $168K | Buy |
+10,000
| New | +$216K | 0.05% | 145 |
|
Northeast Financial Consultants's SPPI Position: Q3 2023 in Review
Northeast Financial Consultants sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 10,000 shares — an estimated $9.6K sold.
Northeast Financial Consultants first reported a position in SPPI in Q3 2018 and held it in 20 quarters. The position peaked at $168K in Q3 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Northeast Financial Consultants reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Northeast Financial Consultants sold 10,000 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $9.6K.
- Northeast Financial Consultants first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 20 quarters.
- Northeast Financial Consultants's Spectrum Pharmaceuticals Inc position peaked at $168K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Northeast Financial Consultants's 13F filing for Q3 2023, filed 14 Nov 2023.